Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study.
Journal Information
Full Title: Cancer Imaging
Abbreviation: Cancer Imaging
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Diagnostic Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateEthics committee approval was received from The First Affiliated Hospital of USTC for a waiver of patient consent (NO.2021-RF-114). Consent for publicationNot applicable. Competing interestsNil. Competing interests Nil."
"Funding This study was supported by the Fundamental Research Funds for the Central Universities (NO.WK9110000061)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025